Five mothers, one missing medicine: Inside the Kota maternity tragedy

Five mothers, one missing medicine: Inside the Kota maternity tragedy Five women who walked into government hospitals expecting to return home with their babies instead became the faces of one of Rajasthan’s worst maternity tragedies. At the center of the investigation is oxytocin, a drug relied upon across the world to prevent fatal bleeding after childbirth, which, it was found, reached Kota hospitals without the very ingredient that makes it work. Between April 4 and 8, five women from different parts of Kota and surrounding areas entered government hospitals with hopes of safely delivering their babies. None of them left with theirs. The cause of the tragedy, according to investigators, lies in a faulty batch of oxytocin supplied to the Government Medical College and JK Lone Hospital. This batch, branded as Tocin, contained no active pharmaceutical ingredient, only sterile water. The women involved included Payal Malaviya, a 26-year-old daily-wage laborer whose dreams extended beyond survival. She had hoped her child would have access to better education than she did. Similarly, Jyoti Verma, a 20-year-old who had recently married outside her caste, was preparing to pursue her own path. Priya Mahawar, another expectant mother, planned to start working as a private tutor to support her family. Shirin, a young bride, and Payal’s husband, Pawan Malaviya, were among those who placed their trust in the hospital system. Their expectations were shattered when complications arose during childbirth. The incident unfolded in rapid succession. On the night of April 5, Payal Malaviya began experiencing heavy bleeding after giving birth. Despite efforts by medical staff, she succumbed to her injuries. Within hours, other women faced similar fates. Jyoti Verma, who had given birth earlier that day, also died due to uncontrolled bleeding. By the end of the week, four more women had perished. Each case was marked by a lack of essential medication that could have saved their lives. Investigations revealed that the oxytocin supply chain failed at multiple points. The drug, which is crucial for preventing postpartum hemorrhage, a leading cause of maternal death globally, was not functioning as intended. Doctors confirmed that without the active ingredient, the drug could not trigger uterine contractions necessary to stop excessive bleeding. In some cases, the absence of oxytocin led to rapid blood loss, depriving vital organs of oxygen and drastically reducing the chance of survival. The failure of the oxytocin supply has sparked a broader crisis. The manufacturer, Jackson Laboratories, has issued a nationwide recall of its products following allegations of substandard manufacturing. State and central drug regulatory authorities have launched investigations into the distribution and handling of the medication. The World Health Organization (WHO) has expressed concern over the incident, highlighting the global implications of such failures in critical healthcare supplies. The impact extends far beyond the hospital walls. For families like Pawan Malaviya’s, the tragedy has left behind grief and unanswered questions. His wife, Payal, had dreamed of providing her child with opportunities she never had. Now, that dream is gone. Other families, too, face the emotional and financial burden of losing loved ones. The loss has forced local communities to confront the reality of inadequate medical resources and systemic gaps in oversight. As the investigation continues, officials are expected to release further findings on how the faulty medication reached the hospitals. Meanwhile, calls for stricter regulation of pharmaceutical supplies in public health systems grow louder. The tragedy underscores the urgent need for improved monitoring and accountability in the procurement and distribution of essential medicines. The fate of these five mothers serves as a grim reminder of the consequences when basic healthcare fails.